Transcription factor 7 like 2 gene polymorphism and advanced glycation end products as risk factors for diabetic nephropathy

Egypt J Immunol. 2024 Jul;31(3):1-14.

Abstract

Hepatocellular carcinoma (HCC) is a multifactorial disease with both genetic and environmental factors contributing to its pathogenesis. ACYP2 is a gene that is related to cell differentiation, apoptosis and prevention of malignant tumors. The ACYP2 gene also affects telomere length. The aim of this study was to evaluate the association between ACYP2 single nucleotide polymorphisms (SNPs) (rs843711), and (rs843706) and incidence of HCC in Egyptian HCC patients. The study included 30 patients with HCC and 30 normal controls. Detection of ACYP2 gene SNPs rs843711, and rs843706 in all study participants was done using real time polymerase chain reaction (RT-PCR). The results showed that all participants including HCC patients and controls carried the heterozygous CA (100%) of the rs843706 SNP (p> 0.05). As for the rs843711, 3.3% of HCC patients had the homozygous TT genotype, 46.7% had the heterozygous CT genotype and 50% had the wild CC genotype, while in the control group, 60% had the heterozygous CT genotype and 40% had the wild CC genotype with no significant difference between both groups (p>0.05). We concluded that there was no association between SNPs ACYP2 rs843706 and rs843711 and occurrence of HCC.

MeSH terms

  • Acylphosphatase
  • Adult
  • Carcinoma, Hepatocellular* / genetics
  • Diabetic Nephropathies* / genetics
  • Egypt
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease* / genetics
  • Genotype
  • Glycation End Products, Advanced* / genetics
  • Humans
  • Liver Neoplasms* / genetics
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide* / genetics
  • Risk Factors

Substances

  • Glycation End Products, Advanced
  • ACYP2 protein, human
  • Acylphosphatase